Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators.

Satkunasivam R, Lo M, Stern M, Gill IS, Fleming S, Wu XC, Anderson RT, Thompson TD, Hamilton AS.

Am J Clin Oncol. 2018 Apr 17. doi: 10.1097/COC.0000000000000442. [Epub ahead of print]

PMID:
29668486
2.

Five-year relative survival for human papillomavirus-associated cancer sites.

Razzaghi H, Saraiya M, Thompson TD, Henley SJ, Viens L, Wilson R.

Cancer. 2018 Jan 1;124(1):203-211. doi: 10.1002/cncr.30947. Epub 2017 Nov 6.

PMID:
29105738
3.

Cognitive bias modification for social anxiety in adults who stutter: a feasibility study of a randomised controlled trial.

McAllister J, Gascoine S, Carroll A, Humby K, Kingston M, Shepstone L, Risebro H, Mackintosh B, Thompson TD, Hodgekins J.

BMJ Open. 2017 Oct 22;7(10):e015601. doi: 10.1136/bmjopen-2016-015601.

4.

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, Zauber AG, Lieberman D, Levin TR, Joseph DA, Nadel MR.

Am J Gastroenterol. 2017 Nov;112(11):1728-1735. doi: 10.1038/ajg.2017.285. Epub 2017 Oct 10.

PMID:
29016558
5.

Cancer Screening Test Use - United States, 2015.

White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC.

MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):201-206. doi: 10.15585/mmwr.mm6608a1.

6.

Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020.

Weir HK, Anderson RN, Coleman King SM, Soman A, Thompson TD, Hong Y, Moller B, Leadbetter S.

Prev Chronic Dis. 2016 Nov 17;13:E157. doi: 10.5888/pcd13.160211.

7.

Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States.

Li J, Thompson TD, Richards TB, Steele CB.

Prev Chronic Dis. 2016 Jul 21;13:E95. doi: 10.5888/pcd13.160148.

8.

Human Papillomavirus-Associated Cancers - United States, 2008-2012.

Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M.

MMWR Morb Mortal Wkly Rep. 2016 Jul 8;65(26):661-6. doi: 10.15585/mmwr.mm6526a1.

9.

Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.

Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ.

Cancer. 2016 Jul 1;122(13):2057-66. doi: 10.1002/cncr.30007. Epub 2016 Apr 28.

10.

Vitamin D and/or calcium deficient diets may differentially affect muscle fiber neuromuscular junction innervation.

Gifondorwa DJ, Thompson TD, Wiley J, Culver AE, Shetler PK, Rocha GV, Ma YL, Krishnan V, Bryant HU.

Muscle Nerve. 2016 Dec;54(6):1120-1132. doi: 10.1002/mus.25146. Epub 2016 Oct 1.

PMID:
27074419
11.

Use and effectiveness of quitlines versus Web-based tobacco cessation interventions among 4 state tobacco control programs.

Neri AJ, Momin BR, Thompson TD, Kahende J, Zhang L, Puckett MC, Stewart SL.

Cancer. 2016 Apr 1;122(7):1126-33. doi: 10.1002/cncr.29739. Epub 2016 Feb 8.

12.

Mammography Use Among Medicare Beneficiaries After Elimination of Cost Sharing.

Sabatino SA, Thompson TD, Guy GP Jr, de Moor JS, Tangka FK.

Med Care. 2016 Apr;54(4):394-9. doi: 10.1097/MLR.0000000000000495.

13.

Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.

Rim SH, Hirsch S, Thomas CC, Brewster WR, Cooney D, Thompson TD, Stewart SL.

World J Obstet Gynecol. 2016;5(2):187-196. doi: 10.5317/wjog.v5.i2.187. Epub 2016 May 10.

14.

Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.

Eheman CR, O'Neil ME, Styles TS, Thompson TD, Morris CR, Babcock FA, Chen VW.

J Registry Manag. 2016 Winter;43(4):179-186.

15.

KRAS testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United States.

Rico A, Pollack LA, Thompson TD, Hsieh MC, Wu XC, Karlitz JJ, West DW, Rainey JM, Chen VW; Enhancement of NPCR for Comparative Effectiveness Research team.

J Cancer Res Ther (Manch). 2016;5(2):7-13. doi: 10.14312/2052-4994.2017-2. Epub 2017 Jan 30.

16.

Human papillomavirus genotype and oropharynx cancer survival in the United States of America.

Goodman MT, Saraiya M, Thompson TD, Steinau M, Hernandez BY, Lynch CF, Lyu CW, Wilkinson EJ, Tucker T, Copeland G, Peters ES, Altekruse S, Unger ER.

Eur J Cancer. 2015 Dec;51(18):2759-67. doi: 10.1016/j.ejca.2015.09.005. Epub 2015 Nov 18.

17.

Providers' knowledge, attitudes, and practices related to colorectal cancer control in Brazil.

Perin DM, Saraiya M, Thompson TD, de Moura L, Simoes EJ, Parra DC, Brownson RC.

Prev Med. 2015 Dec;81:373-9. doi: 10.1016/j.ypmed.2015.09.021. Epub 2015 Oct 9.

18.

Reply to it is not all black and white: Future incidence of stomach cancer will be substantially higher than projected due to the effects of immigration and increasing Hispanic and Asian populations in the United States.

Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S.

Cancer. 2015 Dec 1;121(23):4267-8. doi: 10.1002/cncr.29632. Epub 2015 Aug 17. No abstract available.

19.

Meeting the Healthy People 2020 Objectives to Reduce Cancer Mortality.

Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S, White MC.

Prev Chronic Dis. 2015 Jul 2;12:E104. doi: 10.5888/pcd12.140482.

20.

Hemoptysis: evaluation and management.

Earwood JS, Thompson TD.

Am Fam Physician. 2015 Feb 15;91(4):243-9. Review.

21.

Cancer screening test use - United States, 2013.

Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):464-8.

22.

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup.

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086. Print 2015 Jun.

23.

The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S.

Cancer. 2015 Jun 1;121(11):1827-37. doi: 10.1002/cncr.29258. Epub 2015 Feb 3.

24.

Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States.

Li J, Thompson TD, Tai E, Zhao G, Oster AM.

Prev Chronic Dis. 2014 Nov 13;11:E200. doi: 10.5888/pcd11.140274.

25.

The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.

Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT.

Breast Cancer Res Treat. 2014 Jul;146(1):199-209. doi: 10.1007/s10549-014-2998-3. Epub 2014 Jun 5.

26.

Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.

Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Watson M, Lyu C, Unger ER.

Obstet Gynecol. 2014 Apr;123(4):817-21. doi: 10.1097/AOG.0000000000000171.

27.

Total body skin examination for skin cancer screening among U.S. adults from 2000 to 2010.

Lakhani NA, Saraiya M, Thompson TD, King SC, Guy GP Jr.

Prev Med. 2014 Apr;61:75-80. doi: 10.1016/j.ypmed.2014.01.003. Epub 2014 Jan 10.

28.

US Primary Care Physicians' Prostate Cancer Screening Practices: A Vignette-Based Analysis of Screening Men at High Risk.

Rim SH, Hall IJ, Richards TB, Thompson TD, Richardson LC, Ross LE, Plescia M.

Health Serv Res Manag Epidemiol. 2014 Jan 1;1:2333392814562909.

29.

The effect of multiple primary rules on population-based cancer survival.

Weir HK, Johnson CJ, Thompson TD.

Cancer Causes Control. 2013 Jun;24(6):1231-42. doi: 10.1007/s10552-013-0203-3. Epub 2013 Apr 5.

30.

Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey.

Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, Hawkins NA.

J Cancer Surviv. 2013 Mar;7(1):32-43. doi: 10.1007/s11764-012-0242-x. Epub 2012 Nov 21.

31.

Breast MRI use uncommon among U.S. women.

Miller JW, Sabatino SA, Thompson TD, Breen N, White MC, Ryerson AB, Taplin S, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):159-66. doi: 10.1158/1055-9965.EPI-12-0967. Epub 2012 Nov 15.

32.

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

33.

Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey.

Sabatino SA, Thompson TD, Richardson LC, Miller J.

Med Care. 2012 Mar;50(3):270-6. doi: 10.1097/MLR.0b013e318244d294.

PMID:
22193416
34.

Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.

Smith EK, White MC, Weir HK, Peipins LA, Thompson TD.

Cancer Causes Control. 2012 Jan;23(1):207-11. doi: 10.1007/s10552-011-9855-z. Epub 2011 Oct 21.

35.

In vitro evolution of ligands to the membrane protein caveolin.

Majumdar S, Hajduczki A, Vithayathil R, Olsen TJ, Spitler RM, Mendez AS, Thompson TD, Weiss GA.

J Am Chem Soc. 2011 Jun 29;133(25):9855-62. doi: 10.1021/ja201792q. Epub 2011 Jun 7.

36.

Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008.

Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2011 Jan 14;60(1):42-6. No abstract available.

PMID:
21430619
37.

"In at the deep end": an intensive foundation training in homeopathy for medical students.

Thompson TD, Thompson EA.

Homeopathy. 2009 Apr;98(2):107-13. doi: 10.1016/j.homp.2009.02.008.

PMID:
19358964
38.

Examining the association between socioeconomic status and potential human papillomavirus-associated cancers.

Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, Weir HK.

Cancer. 2008 Nov 15;113(10 Suppl):2910-8. doi: 10.1002/cncr.23742.

39.

Surveillance for cancers associated with tobacco use--United States, 1999-2004.

Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, Thompson TD, Weir HK, Sabatino SA; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2008 Sep 5;57(8):1-33.

40.

Colorectal cancer test use from the 2005 National Health Interview Survey.

Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.

41.

Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.

Ekwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD.

Cancer. 2008 Aug 1;113(3):592-601. doi: 10.1002/cncr.23613.

42.

Cancer incidence among children and adolescents in the United States, 2001-2003.

Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL.

Pediatrics. 2008 Jun;121(6):e1470-7. doi: 10.1542/peds.2007-2964.

PMID:
18519450
43.

Racial and ethnic differences in mammography use among U.S. women younger than age 40.

Kapp JM, Ryerson AB, Coughlin SS, Thompson TD.

Breast Cancer Res Treat. 2009 Jan;113(2):327-37. doi: 10.1007/s10549-008-9919-2. Epub 2008 Feb 9.

PMID:
18264758
44.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
46.

CAM before the storm: authors' reply.

Thompson TD, Feder G.

BMJ. 2005 Nov 19;331(7526):1205. No abstract available.

47.

Prostate cancer incidence and mortality rates and trends in the United States and Canada.

McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD.

Public Health Rep. 2004 Mar-Apr;119(2):174-86.

48.

Cancer mortality surveillance--United States, 1990-2000.

Stewart SL, King JB, Thompson TD, Friedman C, Wingo PA.

MMWR Surveill Summ. 2004 Jun 4;53(3):1-108.

49.

Supplemental Content

Loading ...
Support Center